Biosynthesis of methylated resveratrol analogs through the construction of an artificial biosynthetic pathway in E. coli

BMC Biotechnology

Volumn 14, Issue , 2014, Pages

  Kang, Sun Young ^a,b   Lee, Jae K ^a,b   Choi, Oksik ^a   Kim, Cha Y ^a   Jang, Jae Hyuk ^a   Hwang, Bang Y ^b   Hong, Young Soo ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOSYNTHESIS; ESCHERICHIA COLI; EXTRACTION; GENES;

BIOSYNTHETIC GENE; BIOSYNTHETIC PATHWAY; ECONOMIC PROBLEMS; INDUSTRIAL MATERIALS; LARGE-SCALE PRODUCTION; O-METHYLTRANSFERASE; PLANT METABOLITES; PRECURSOR FEEDING; E. COLI;

RESVERATROL;

3,4' DIMETHOXY 5 HYDROXYSTILBENE; 3,5 DIHYDROXY 4' METHOXYSTILBENE; 3,5,4' TRIMETHOXYSTILBENE; BIS METHYL RESVERATROL( 3,4' DIMETHOXY 5 HYDROXYSTILBENE); CARBON; METHYLTRANSFERASE; PHENOL DERIVATIVE; PINOSTILBENE; PINOSTILBENE( 3,4' DIHYDROXY 5 METHOXYSTILBENE); PLANT MEDICINAL PRODUCT; RESVERATROL; RESVERATROL DERIVATIVE; STILBENE DERIVATIVE; TRIMETHYLRESVERATROL( 3,5,4' TRIMETHOXYSTILBENE); UNCLASSIFIED DRUG; 3,5-DIHYDROXY-4'-METHOXYSTILBENE; VEGETABLE PROTEIN; PINOSTILBENE (3,4' DIHYDROXY 5 METHOXYSTILBENE); TRI METHYL RESVERATROL (3,5,4' TRIMETHOXYSTILBENE);

ANIMAL CELL; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BIOSYNTHESIS; BIOTRANSFORMATION; CARBON SOURCE; CODON; CONTROLLED STUDY; DRUG SYNTHESIS; ESCHERICHIA COLI; EXTRACTION; GENBANK; GENE EXPRESSION; LARGE SCALE PRODUCTION; METHYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANT METABOLISM; SORGHUM; CHEMISTRY; ENZYMOLOGY; GENE VECTOR; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; GENE CLUSTER;

ESCHERICHIA COLI; HARNESS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESCHERICHIA COLI; GENETIC VECTORS; MASS SPECTROMETRY; METHYLATION; METHYLTRANSFERASES; PLANT PROTEINS; SORGHUM; STILBENES;

EID: 84904272271     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-14-67     Document Type: Article

References (31)

1. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275(5297):218-220.
2. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006, 5(6):493-506.
3. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444(7117):337-342.
4. Legg K. Metabolic disease: identifying novel targets of resveratrol. Nat Rev Drug Discov 2012, 11(4):273.
5. Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 2004, 32(12):1377-1382.
6. Tolomeo M, Grimaudo S, Di Cristina A, Roberti M, Pizzirani D, Meli M, Dusonchet L, Gebbia N, Abbadessa V, Crosta L, Barucchello R, Grisolia G, Invidiata F, Simoni D. Pterostilbene and 3'-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. Int J Biochem Cell Biol 2005, 37(8):1709-1726.
7. Mikstacka R, Przybylska D, Rimando AM, Baer-Dubowska W. Inhibition of human recombinant cytochromes P450 CYP1A1 and CYP1B1 by trans-resveratrol methyl ethers. Mol Nutr Food Res 2007, 51(5):517-524.
8. Rimando AM, Suh N. Biological/chemopreventive activity of stilbenes and their effect on colon cancer. Planta Med 2008, 74(13):1635-1643.
9. Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol 2011, 68(3):593-601.
10. Simoni D, Roberti M, Invidiata FP, Aiello E, Aiello S, Marchetti P, Baruchello R, Eleopra M, Di Cristina A, Grimaudo S, Gebbia N, Crosta L, Dieli F, Tolomeo M. Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism. Bioorg Med Chem Lett 2006, 16(12):3245-3248.
11. Schneider Y, Chabert P, Stutzmann J, Coelho D, Fougerousse A, Gosse F, Launay JF, Brouillard R, Raul F. Resveratrol analog (Z)-3,5,4'-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization. Int J Cancer 2003, 107(2):189-196.
12. Baerson SR, Dayan FE, Rimando AM, Nanayakkara NP, Liu CJ, Schroder J, Fishbein M, Pan Z, Kagan IA, Pratt LH, Cordonnier-Pratt MM, Duke SO. A functional genomics investigation of allelochemical biosynthesis in Sorghum bicolor root hairs. J Biol Chem 2008, 283(6):3231-3247.
13. Rimando AM, Pan Z, Polashock JJ, Dayan FE, Mizuno CS, Snook ME, Liu CJ, Baerson SR. In planta production of the highly potent resveratrol analogue pterostilbene via stilbene synthase and O-methyltransferase co-expression. Plant Biotechnol J 2012, 10(3):269-283.
14. Chiron H, Drouet A, Claudot AC, Eckerskorn C, Trost M, Heller W, Ernst D, Sandermann H. Molecular cloning and functional expression of a stress-induced multifunctional O-methyltransferase with pinosylvin methyltransferase activity from Scots pine (Pinus sylvestris L.). Plant Mol Biol 2000, 44(6):733-745.
15. Katsuyama Y, Funa N, Horinouchi S. Precursor-directed biosynthesis of stilbene methyl ethers in Escherichia coli. Biotechnol J 2007, 2(10):1286-1293.
16. Jeong YJ, An CH, Woo SG, Jeong HJ, Kim YM, Park SJ, Yoon BD, Kim CY. Production of pinostilbene compounds by the expression of resveratrol O-methyltransferase genes in Escherichia coli. Enzyme Microb Technol 2014, 54:8-14.
17. Schmidlin L, Poutaraud A, Claudel P, Mestre P, Prado E, Santos-Rosa M, Wiedemann-Merdinoglu S, Karst F, Merdinoglu D, Hugueney P. A stress-inducible resveratrol O-methyltransferase involved in the biosynthesis of pterostilbene in grapevine. Plant Physiol 2008, 148(3):1630-1639.
18. Choi O, Wu CZ, Kang SY, Ahn JS, Uhm TB, Hong YS. Biosynthesis of plant-specific phenylpropanoids by construction of an artificial biosynthetic pathway in Escherichia coli. J Ind Microbiol Biotechnol 2011, 38(10):1657-1665.
19. Horinouchi S. Combinatorial biosynthesis of plant medicinal polyketides by microorganisms. Curr Opin Chem Biol 2009, 13(2):197-204.
20. Katsuyama Y, Funa N, Miyahisa I, Horinouchi S. Synthesis of unnatural flavonoids and stilbenes by exploiting the plant biosynthetic pathway in Escherichia coli. Chem Biol 2007, 14(6):613-621.
21. Watts KT, Lee PC, Schmidt-Dannert C. Biosynthesis of plant-specific stilbene polyketides in metabolically engineered Escherichia coli. BMC Biotechnol 2006, 6:22.
22. Wu J, Liu P, Fan Y, Bao H, Du G, Zhou J, Chen J. Multivariate modular metabolic engineering of Escherichia coli to produce resveratrol from L-tyrosine. J Biotechnol 2013, 167(4):404-411.
23. Lim CG, Fowler ZL, Hueller T, Schaffer S, Koffas MA. High-yield resveratrol production in engineered Escherichia coli. Appl Environ Microbiol 2011, 77(10):3451-3460.
24. Trantas E, Panopoulos N, Ververidis F. Metabolic engineering of the complete pathway leading to heterologous biosynthesis of various flavonoids and stilbenoids in Saccharomyces cerevisiae. Metab Eng 2009, 11(6):355-366.
25. Zhang Y, Li SZ, Li J, Pan X, Cahoon RE, Jaworski JG, Wang X, Jez JM, Chen F, Yu O. Using unnatural protein fusions to engineer resveratrol biosynthesis in yeast and Mammalian cells. J Am Chem Soc 2006, 128(40):13030-13031.
26. Gergely M, Pour NMS, Zoltan S, Katalin B, Tamas L, Robert O, Laszlo M. Determination of products derived from trans-resveratrol UV photoisomerisation by means of HPLC-APCI-MS. J Photochem Photobiol Chem 2008, 196:44-50.
27. Sivakumar B, Murugan R, Baskaran A, Khadangale BP, Murugan S, Senthilkumar UP. Identification and characterization of process-related impurities of trans-resveratrol. Sci Pharm 2013, 81(3):683-695.
28. Fowler ZL, Koffas MA. Biosynthesis and biotechnological production of flavanones: current state and perspectives. Appl Microbiol Biotechnol 2009, 83(5):799-808.
29. Kaneko M, Hwang EI, Ohnishi Y, Horinouchi S. Heterologous production of flavanones in Escherichia coli: potential for combinatorial biosynthesis of flavonoids in bacteria. J Ind Microbiol Biotechnol 2003, 30(8):456-461.
30. Miroux B, Walker JE. Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels. J Mol Biol 1996, 260(3):289-298.
31. Kang SY, Choi O, Lee JK, Hwang BY, Uhm TB, Hong YS. Artificial biosynthesis of phenylpropanoic acids in a tyrosine overproducing Escherichia coli strain. Microb Cell Fact 2012, 11:153.